Page last updated: 2024-12-08

16-hydroxyandrost-4-en-3,17-dione

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

16-hydroxyandrost-4-en-3,17-dione is a **steroid hormone** with a chemical structure similar to testosterone. It's also known as **16α-hydroxytestosterone**.

**Here's why it's important for research:**

* **Potential Therapeutic Applications:** Research suggests 16-hydroxyandrost-4-en-3,17-dione might have potential therapeutic applications for:
* **Muscle growth and strength:** It's shown to have anabolic effects, potentially aiding muscle development.
* **Neuroprotection:** Some studies suggest it may protect brain cells from damage.
* **Treating certain cancers:** There's evidence of anti-cancer activity against some types of tumors.
* **Metabolic Effects:** It's also being studied for its role in metabolism and its possible effects on things like:
* **Lipid profiles (cholesterol, triglycerides, etc.)**
* **Glucose regulation**
* **Understanding Steroid Metabolism:** Research on 16-hydroxyandrost-4-en-3,17-dione can help scientists better understand the complex processes of steroid metabolism in the body. This knowledge could have implications for:
* **Developing more effective drugs**
* **Preventing and treating steroid-related diseases**

**It's important to note:**

* **Clinical Research is Ongoing:** Much of the research on 16-hydroxyandrost-4-en-3,17-dione is still in early stages, and more studies are needed to fully understand its safety, effectiveness, and potential applications.
* **Potential Side Effects:** As with any steroid hormone, 16-hydroxyandrost-4-en-3,17-dione could have potential side effects. Further research is needed to determine the risks associated with its use.

**Overall, 16-hydroxyandrost-4-en-3,17-dione is an intriguing molecule with potential therapeutic benefits. Continued research is crucial to understand its full potential and ensure its safe and effective use.**

16-hydroxyandrost-4-en-3,17-dione: RN given refers to cpd without isomeric designation; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID160789
MeSH IDM0069505

Synonyms (6)

Synonym
16-hydroxyandrost-4-ene-3,17-dione
5746-45-2
16-hydroxyandrost-4-en-3,17-dione
16alpha-hydroxyandrost-4-en-3,17-dione
16alpha-ohad
DTXSID30972943
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (19)

TimeframeStudies, This Drug (%)All Drugs %
pre-19908 (42.11)18.7374
1990's4 (21.05)18.2507
2000's6 (31.58)29.6817
2010's1 (5.26)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.15

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.15 (24.57)
Research Supply Index3.04 (2.92)
Research Growth Index4.20 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.15)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other20 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]